124 related articles for article (PubMed ID: 8942015)
1. Effect of clonidine on the height of a child with glycogen storage disease type VI: a 13 year follow-up study.
Asami T; Kikuchi T; Asami K; Uchiyama M
Acta Paediatr Jpn; 1996 Oct; 38(5):524-8. PubMed ID: 8942015
[TBL] [Abstract][Full Text] [Related]
2. Clonidine treatment for short stature.
Pintor C; Cella SG; Loche S; Puggioni R; Corda R; Locatelli V; Müller EE
Lancet; 1987 May; 1(8544):1226-30. PubMed ID: 2884368
[TBL] [Abstract][Full Text] [Related]
3. [Effects of clonidine++ administration in children with familial short stature and retarded body growth].
Dorantes-Alvarez L; Coyote-Estrada N; Parra-Paredes S; García-Morales L; Metlich-Medlich B
Bol Med Hosp Infant Mex; 1992 Jul; 49(7):422-6. PubMed ID: 1418649
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of growth-promoting therapies. Comparison among growth hormone, clonidine, and levodopa.
Volta C; Ghizzoni L; Muto G; Spaggiari R; Virdis R; Bernasconi S
Am J Dis Child; 1991 Feb; 145(2):168-71. PubMed ID: 1994682
[TBL] [Abstract][Full Text] [Related]
5. Glycogen Storage Disease Type VI With a Novel Mutation in PYGL Gene.
Jagadisan B; Ranganath P
Indian Pediatr; 2017 Sep; 54(9):775-776. PubMed ID: 28984260
[TBL] [Abstract][Full Text] [Related]
6. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic spectrum of GSD type 6 in Korea.
Hahn JW; Lee H; Seong MW; Kang GH; Moon JS; Ko JS
Orphanet J Rare Dis; 2023 Jun; 18(1):132. PubMed ID: 37264426
[TBL] [Abstract][Full Text] [Related]
8. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
Allen DB
J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
[TBL] [Abstract][Full Text] [Related]
9. Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial.
Pescovitz OH; Tan E
Lancet; 1988 Oct; 2(8616):874-7. PubMed ID: 2902319
[TBL] [Abstract][Full Text] [Related]
10. Novel PYGL mutations in Chinese children leading to glycogen storage disease type VI: two case reports.
Luo X; Hu J; Gao X; Fan Y; Sun Y; Gu X; Qiu W
BMC Med Genet; 2020 Apr; 21(1):74. PubMed ID: 32268899
[TBL] [Abstract][Full Text] [Related]
11. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with growth hormone of children with short stature and normal growth hormone secretion.
Moore WV; Moore KC; Gifford R; Hollowell JG; Donaldson DL
J Pediatr; 1992 May; 120(5):702-8. PubMed ID: 1578304
[TBL] [Abstract][Full Text] [Related]
13. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.
Roscher A; Patel J; Hewson S; Nagy L; Feigenbaum A; Kronick J; Raiman J; Schulze A; Siriwardena K; Mercimek-Mahmutoglu S
Mol Genet Metab; 2014 Nov; 113(3):171-6. PubMed ID: 25266922
[TBL] [Abstract][Full Text] [Related]
14. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
Fjellestad-Paulsen A; Simon D; Czernichow P
J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and follow-up of glycogen storage disease (GSD) type VI from the largest GSD center in China.
Luo X; Duan Y; Fang D; Sun Y; Xiao B; Zhang H; Han L; Liang L; Gong Z; Gu X; Yu Y; Qiu W
Hum Mutat; 2022 May; 43(5):557-567. PubMed ID: 35143115
[TBL] [Abstract][Full Text] [Related]
16. Hepatic ultrasound findings in the glycogen storage diseases.
Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C
Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397
[TBL] [Abstract][Full Text] [Related]
17. Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review.
Lu SQ; Feng JY; Liu J; Xie XB; Lu Y; Abuduxikuer K
J Pediatr Endocrinol Metab; 2020 Sep; 33(10):1321-1333. PubMed ID: 32892177
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic glycogenosis: the clinical, biochemical and enzymatic aspects in a group of pediatric patients].
Castro de Kolster C; Rolo M; Arias S; Guerreiro N; Carvajal A; Castro J; Kolster J
G E N; 1992; 46(3):191-8. PubMed ID: 1340824
[TBL] [Abstract][Full Text] [Related]
19. Hepatic glycogen storage disorders: what have we learned in recent years?
Burda P; Hochuli M
Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
[TBL] [Abstract][Full Text] [Related]
20. Liver histology in children with glycogen storage disorders type VI and IX.
Degrassi I; Deheragoda M; Creegen D; Mundy H; Mustafa A; Vara R; Hadzic N
Dig Liver Dis; 2021 Jan; 53(1):86-93. PubMed ID: 32505569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
